A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL
A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL
Recruiting · NCT06086197 · Registry updated 2024-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 2 | 2024-06-25 | NCT06086197 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Cancer Hospital | 142 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |